Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Expert Rev Vaccines. 2016 Mar 16;15(8):1041–1053. doi: 10.1586/14760584.2016.1159135

Table 2.

Protective efficacy of antibody to the dPNAG glycoform against various microbial pathogens in mouse settings of infection.

S. aureus: lethal peritonitis, bacteremia, skin infection, pneumonia, keratitis
E. coli: lethal peritonitis, GI infection by Stx+ strains, systemic infection by multidrug resistant strains
Burkholderia cenocepacia: lethal peritonitis
A. baumannii: bacteremia and pneumonia
N. meningitidis serogroup B: neonatal mouse meningitis infection
S. pyogenes, skin infection leading to lethal systemic infection
L. monocytogenes: systemic infection
S. pneumoniae: pneumonia
C. albicans: keratitis
Plasmodium berghei ANKA: mouse malaria